Monograph: |
CADEXOMER IODINE
BENEFITS
β’ BACTERICIDAL AGAINST 103 ISOLATES OF MRSA AND 101 STRAINS OF P. AERUGINOSA (IN VITRO)
β’ PROVIDES BROAD-SPECTRUM ANTIMICROBIAL ACTIVITY UP TO 72 HOURS
β’ REMOVES EXUDATE AND DEBRIS, LEADING TO EFFECTIVE WOUND BED PREPARATION/DESLOUGHING
β’ EACH GRAM ABSORBS UP TO APPROXIMATELY 3ML OF FLUID
β’ COLOR CHANGE FROM BROWN TO YELLOW/GRAY INDICATES THE DRESSING SHOULD BE CHANGED
INDICATIONS
IODOSORB* CONTAINS 0.9% WEIGHT PER WEIGHT IODINE AND SHOULD NOT BE USED IN PATIENTS WITH KNOWN OR SUSPECTED IODINE SENSITIVITY.
IODOSORB* CADEXOMER IODINE GEL IS INDICATED FOR USE IN CLEANING WET ULCERS AND WOUNDS SUCH AS VENOUS ULCERS, PRESSURE ULCERS, DIABETIC ULCERS AND INFECTED TRAUMATIC AND SURGICAL WOUNDS.
CONTRAINDICATIONS
IODOSORB* DRESSINGS ARE CONTRAINDICATED IN PATIENTS WITH HASHIMOTO'S THYROIDITIS OR PATIENTS WITH A HISTORY OF GRAVE'S DISEASE OR NON-TOXIC NODULAR GOITER. PATIENTS WITH A HISTORY OF ANY THYROID DISORDER ARE MORE SUSCEPTIBLE TO ALTERATION IN THYROID METABOLISM WITH LONG-TERM IODOSORB* THERAPY. NOT TO BE USED BY PREGNANT OR LACTATING WOMEN AS IODINE IS ABSORBED SYSTEMICALLY. IODOSORB* IS NOT EFFECTIVE IN CLEANING DRY WOUNDS.
WARNINGS AND PRECAUTIONS
THE TOTAL AMOUNT OF IODOSORB* USED IN ONE WEEK MUST NOT EXCEED 5.3OZ (150G) AND A SINGLE APPLICATION SHOULD NOT EXCEED 1.8OZ (50G), UNLESS A DOCTOR HAS ADVISED OTHERWISE. DO NOT USE CONTINUOUSLY FOR MORE THAN THREE MONTHS. TO MINIMIZE THE POSSIBILITY OF CROSS-CONTAMINATION, A SINGLE IODOSORB* PAD SHOULD BE LIMITED TO USE ON ONE PATIENT.
ADVERSE EFFECTS/REACTIONS
SOME PATIENTS MAY EXPERIENCE SLIGHT TRANSIENT PAIN DURING THE FIRST HOUR OF APPLICATION
|